SWP Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$423K Sell
3,831
-3,821
-50% -$369K 0.2% 51
2026
Q2
$599K Hold
7,652
– – 0.28% 44
2026
Q1
$495K Hold
7,652
– – 0.25% 45
2025
Q4
$515K Hold
7,652
– – 0.26% 43
2025
Q3
$561K Hold
7,652
– – 0.29% 43
2025
Q2
$398K Hold
7,652
– – 0.22% 49
2025
Q1
$488K Hold
7,652
– – 0.3% 43
2024
Q4
$366K Buy
+7,652
New +$392K 0.22% 45

Other funds holding HALO

SWP Financial's HALO Position: Q3 2026 in Review

SWP Financial reduced its Halozyme (HALO) stake by 50% in Q3 2026, selling an estimated $369K and leaving 3,831 shares worth $423K. The position accounts for 0.2% of the portfolio, ranked #51.

SWP Financial first reported a position in HALO in Q4 2024 and has held it in 8 quarters since. The position peaked at $599K in Q2 2026. 482 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • SWP Financial held 3,831 shares of Halozyme worth $423K as of Q3 2026.
  • SWP Financial sold 3,821 Halozyme shares in Q3 2026, an estimated $369K.
  • Halozyme made up 0.2% of SWP Financial's portfolio in Q3 2026, its #51 holding.
  • SWP Financial first reported a position in Halozyme in Q4 2024 and has held it in 8 quarters since.
  • SWP Financial's Halozyme position peaked at $599K in Q2 2026.
  • 482 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on SWP Financial's 13F filing for Q3 2026, filed 23 Oct 2026.